Free shipping on antibody orders delivered to Canada

Blog

     Yesterday, the second 5 à 7 from the 2018-2019 season of the Montreal Immunology Meetings was held in downtown Montréal. Again it was a pleasure to see all those scientists reunited to listen to the two different talks on subjects related to immunology. For the official announcements or to know the dates of the future events, you can visit their website directly here. We can only acknowledge the great job done by the organizing committee year after year. Cheers!

read more

     When tumor cells are too far from blood supply, the different signals associated with hypoxia will be emitted. This will trigger the complex remodeling process called angiogenesis. It is associated with an increase in the tumor malignancy and propensity to invade other tissues. Cancer cells will secrete different factors to harness the vascular system in order to irrigate the tumor.

read more
November 22nd 2018 - New publication! MM-0015-P

     The presence of extracellular amyloid-beta plaques and tau neurofibrillary tangles has been a key neuropathological signature of Alzheimer's disease (AD) in post-mortem analysis of patients. The generally accepted hypothesis is that pathological accumulation of toxic amyloid-beta peptides initiates the cascade of events leading to tau neurofibrillary tangles formation and to the progressive decline in cognition. 

read more

     Held at the Bellini building of the McGill Life Science Complex, this biotech-connect show is a good opportunity to ask us how we can help you with your projects.

read more
October 26th 2018 - Akt activation pathway

     Akt is a subfamily of serine/threonine kinases (Protein Kinase B) that includes AKT1, AKT2, and AKT3. Akt resides in the cytosol in an inactive conformation, until the cell is stimulated leading to the activation of PI3K and the conversion of plasma membrane phospholipid PIP-2 to PIP3. After being recruited to the membrane, Akt is phosphorylated and activated by PDK1 and multiple catalytic proteins.

read more
October 18th 2018 - IDIGH symposium and product show

     Infectious Diseases and Immunity in Global Health Program (IDIGH) has been developed at McGill University to maximize the research effort with a translational focus. We are proud to sponsor their yearly symposium which will be held on Friday, October 19, 2018. In so doing, MédiMabs affirms its continuity in bringing new products on the market and in developing de novo antibodies with research partners in the field of infectious diseases.

read more
October 18th 2018 - TLR4, 20 years later

    20 years ago, in 1998, two research groups, Bruce Beutler’s and Shizuo Akira’s, have identified TLR4 as the LPS (Lipopolysaccharide) receptor, a key molecule in elucidating the mechanism behind innate immunity activation.(1) Briefly, LPS will be recognized by LPB and form the LPS-LBP complex which will bind to CD14. This interaction will facilitate the transfer of LPS to MD-2 a molecule associated with the extracellular portion of TLR4.

read more
October 12th 2018 - Montreal Immunology Meetings

     Montreal Immunology Meetings are a local initiative from researchers in immunology related fields. They organize small presentations from experts on trendy interesting topics in a cozy atmosphere. Students, lab managers and researchers are invited to these 5 à 7 meetings to favor exchanges between novices and experts. We are proud to sponsor this event for another year and wish a good 2018-2019 5à7 season to the organizers.

read more

     The cellular microenvironment can modulate intracellular pathways, these interactions can occur in normal or physiopathological conditions.

read more